search
Back to results

Influence of an Innovative Telemetric Smartphone Application on Re-hospitalization (TRACE-AF)

Primary Purpose

Paroxysmal Atrial Fibrillation

Status
Unknown status
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Telemetric smartphone application
Conventional follow up
Sponsored by
Universitätsklinikum Hamburg-Eppendorf
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Paroxysmal Atrial Fibrillation focused on measuring Paroxysmal Atrial Fibrillation, Pulmonary Vein Isolation, Telemetry Monitoring, Cryoballoon ablation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age > 18 years
  • Written informed consent
  • symptomatic paroxysmal atrial fibrillation (at least two episodes within 3 months prior to ablation)
  • cryoballoon pulmonary vein isolation
  • possession of a compatible smartphone

Exclusion Criteria:

  • Age < 18 years
  • persistent or permanent atrial fibrillation (AF)
  • prior catheter or surgical ablation of AF
  • pregnant females
  • contraindication for oral anticoagulation
  • manifest hyper-/hypothyroidism
  • no intention to cooperate
  • alcoholism

Sites / Locations

  • Asklepios St Georg
  • Universitätsklinikum Hamburg-EppendorfRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Experimental

Arm Label

Conventional follow up

Telemetric smartphone application

Arm Description

Conventional follow up at physician practice

Structured follow up with a telemetric smartphone application

Outcomes

Primary Outcome Measures

Rehospitalization Recurrence of AF
Rate of rehospitalization after cryoballoon pulmonary vein isolation in patients with paroxysmal atrial fibrillation, Recurrence of sustained atrial fibrillation (>30 seconds) after atrial fibrillation ablation

Secondary Outcome Measures

Full Information

First Posted
August 2, 2017
Last Updated
June 15, 2019
Sponsor
Universitätsklinikum Hamburg-Eppendorf
search

1. Study Identification

Unique Protocol Identification Number
NCT03268707
Brief Title
Influence of an Innovative Telemetric Smartphone Application on Re-hospitalization
Acronym
TRACE-AF
Official Title
Influence of an Innovative Telemetric Smartphone Application on Re-hospitalization And Quality of Life After Cryoballoon Pulmonary vEin Isolation in Patients With Paroxysmal Atrial Fibrillation
Study Type
Interventional

2. Study Status

Record Verification Date
June 2019
Overall Recruitment Status
Unknown status
Study Start Date
July 15, 2017 (Actual)
Primary Completion Date
December 31, 2020 (Anticipated)
Study Completion Date
June 30, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Universitätsklinikum Hamburg-Eppendorf

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
A randomized, open, mono-centric pilot study to investigate the influence of an innovative telemetric smartphone application on re-hospitalization and quality of life after cryoballoon pulmonary vein isolation in patients with paroxysmal atrial fibrillation.
Detailed Description
The telemetric smartphone application includes a digitized medical record, a mobile ECG device and a 24-hour on call service by a cardiologist. The hypothesis is that the use of a telemetric smartphone application can reduce re-hospitalization in patients after cryoballoon pulmonary vein isolation. Secondary endpoints are quality of life measurements, health care cost calculations and recurrences of atrial fibrillation after ablation. All patients will undergo ablation and will be randomized into two groups: 1) conventional follow up with outpatient visits 6 and 12 months after ablation compared to 2) a structured follow up with the smartphone application, a mobile ECG device (patients will be able to send in as many ECGs as wanted), up to three phone calls with a cardiologist (24-hour on call service) as well as outpatient visits 6 and 12 months after cryo-ablation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Paroxysmal Atrial Fibrillation
Keywords
Paroxysmal Atrial Fibrillation, Pulmonary Vein Isolation, Telemetry Monitoring, Cryoballoon ablation

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Conventional follow up
Arm Type
Other
Arm Description
Conventional follow up at physician practice
Arm Title
Telemetric smartphone application
Arm Type
Experimental
Arm Description
Structured follow up with a telemetric smartphone application
Intervention Type
Device
Intervention Name(s)
Telemetric smartphone application
Intervention Description
Structured follow up with a telemetric smartphone application
Intervention Type
Other
Intervention Name(s)
Conventional follow up
Intervention Description
Conventional follow up at physician practice
Primary Outcome Measure Information:
Title
Rehospitalization Recurrence of AF
Description
Rate of rehospitalization after cryoballoon pulmonary vein isolation in patients with paroxysmal atrial fibrillation, Recurrence of sustained atrial fibrillation (>30 seconds) after atrial fibrillation ablation
Time Frame
in 12 months follow up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age > 18 years Written informed consent symptomatic paroxysmal atrial fibrillation (at least two episodes within 3 months prior to ablation) cryoballoon pulmonary vein isolation possession of a compatible smartphone Exclusion Criteria: Age < 18 years persistent or permanent atrial fibrillation (AF) prior catheter or surgical ablation of AF pregnant females contraindication for oral anticoagulation manifest hyper-/hypothyroidism no intention to cooperate alcoholism
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Melanie Gunawardene, MD
Phone
004940741054120
Email
m.gunawardene@uke.de
First Name & Middle Initial & Last Name or Official Title & Degree
Christian Meyer, MD
Phone
004940741054120
Email
chr.meyer@uke.de
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christian Meyer, MD
Organizational Affiliation
Universitaeres Herzzentrum Hamburg GmbH
Official's Role
Principal Investigator
Facility Information:
Facility Name
Asklepios St Georg
City
Hamburg
ZIP/Postal Code
20246
Country
Germany
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Stephan Willems
Phone
49 40 181885-3034
Email
s.willems@asklepios.com
First Name & Middle Initial & Last Name & Degree
Kai Jaquet
Phone
49 40 181885-3034
Email
k.jaquet@asklepios.com
Facility Name
Universitätsklinikum Hamburg-Eppendorf
City
Hamburg
ZIP/Postal Code
20246
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Melanie Gunawardene
Phone
40741059471
Email
m.gunawardene@uke.de
First Name & Middle Initial & Last Name & Degree
Christian Meyer
Phone
40741059471
Email
chr.meyer@uke.de

12. IPD Sharing Statement

Learn more about this trial

Influence of an Innovative Telemetric Smartphone Application on Re-hospitalization

We'll reach out to this number within 24 hrs